Skip to main content
Fig. 4 | European Journal of Medical Research

Fig. 4

From: Inhibitory activities of vitamins K2 against clinical isolates of quinolone-resistant and methicillin-resistant Staphylococcus aureus (QR-MRSA) with different multi-locus sequence types (MLST), SCCmec, and spa types

Fig. 4

Differences in gene expression levels of norA, gyrA, grlA, gyrB and grlB genes in treated S. aureus isolates with vitamin K2. a norA, gyrA, grlA, gyrB and grlB gene expressions in fluroquinolone resistnt strains. b norA, gyrA, grlA, gyrB and grlB gene expressions after treatment with vitamin K2 in MRSA strains. c norA, gyrA, grlA, gyrB and grlB gene expressions in MDR strains. d norA, gyrA, grlA, gyrB and grlB gene expressions in XDR strains. Experiments performed in triplicate Medians are shown. Statistics: Kruskal–Wallis one-way analysis of variance (ANOVA) with uncorrected Dunn’s test. *P < 0.05; **P < 0.01; ***P < 0.001; n.s., not significant

Back to article page

European Journal of Medical Research

ISSN: 2047-783X

Contact us